NCT07098416

A Real-World Study About Anemia in Chronic Kidney Disease in China（DASHENG）

An In-Depth Analysis of the Present Diagnostic and Therapeutic Landscape for Renal Anemia in China's Real-World Clinical Environment: A Multicenter Retrospective Cohort Investigation（DASHENG Study）

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 20,000 (estimated)
• Sponsor: Wei Chen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Anemia affects the quality of life of CKD patients and increases the risk of CKD progression. we conducted a real-world study on patients with anemia in CKD to analyze the disease characteristics and treatment in Chinese patients with CKD-anemia.

Detailed description

Anemia adversely affects the quality of life of CKD patients and increases the risk of CKD progression. This study utilize data from approximately 20 medical centers across China. It aims to: 1. Analyze the disease characteristics, current diagnostic and treatments in Chinese patients with CKD-anemia. 2. Evaluate the safety and efficacy profiles of different drugs used for CKD-anemia. 3. Explore the direct medical costs associated with CKD-anemia management within real-world clinical practice in China.

Conditions

• Anemia in Chronic Kidney Disease

Timeline

• Start date: 2025-08-01
• Primary completion: 2026-08-31
• Completion: 2027-08-31
• First posted: 2025-08-01
• Last updated: 2025-08-01

Locations

1 site across 1 country: China